1,756 top medical experts on Artificial Respiration across 56 countries and 45 U.S. states, including 1,682 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Artificial Respiration: Any method of artificial breathing that employs mechanical or non-mechanical means to force the air into and out of the lungs. Artificial respiration or ventilation is used in individuals who have stopped breathing or have respiratory insufficiency to increase their intake of oxygen (O2) and excretion of carbon dioxide (CO2).
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Resuscitation (4,214), Airway Management (2,374), Respiratory Therapy (3,847) and Narrower Categories: High-Frequency Ventilation (1,687), Interactive Ventilatory Support (1,011), Liquid Ventilation (205), Noninvasive Ventilation (2,868), One-Lung Ventilation (1,431), Positive-Pressure Respiration (2,823), Ventilator Weaning (1,387).
- Synonyms: Mechanical Ventilation
- Brochard, Laurent JInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada; Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, Ontario, Canada. Electronic address: .Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Diaphragm; Ventilator-Induced Lung Injury; Intensive Care Units; Respiratory InsufficiencyCategories: Methods; Therapy; Physiology; Adverse Effects; Physiopathology; Mortality
- Fan, EddyInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Extracorporeal Membrane Oxygenation; Critical Illness; Respiratory Insufficiency; DiaphragmCategories: Therapy; Methods; Mortality; Standards; Adverse Effects; Therapeutic Use
- Ferguson, Niall DInter-Departmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Diaphragm; Respiratory Insufficiency; Critical Illness; High-Frequency VentilationCategories: Therapy; Methods; Mortality; Adverse Effects; Administration & Dosage; Physiology
- Pelosi, PaoloAnesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy.Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Lung; Postoperative Complications; Ventilator-Induced Lung Injury; Tidal VolumeCategories: Methods; Therapy; Prevention & Control; Physiopathology; Adverse Effects; Physiology
- Goligher, Ewan CInterdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada.Subjects: Respiration, Artificial; Diaphragm; Respiratory Distress Syndrome; Ventilator-Induced Lung Injury; Extracorporeal Membrane Oxygenation; Idiopathic Pulmonary FibrosisCategories: Methods; Therapy; Physiology; Adverse Effects; Diagnostic Imaging; Prevention & Control
- Brodie, Daniel Critical Care MedicineDepartment of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Extracorporeal Membrane Oxygenation; COVID-19; Coronavirus Infections; Pneumonia, ViralCategories: Methods; Therapy; Standards; Blood; Complications; Prevention & Control
- Brower, Roy G Pulmonary DiseaseDivision of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland. Top HospitalDisclosed payments in 2021 from 4 biomedical companies, totalling $5,137.5, including $3,937.5 from Allergan, Inc.Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Intensive Care Units; Acute Lung Injury; Respiratory Insufficiency; Deep SedationCategories: Methods; Therapy; Mortality; Statistics & Numerical Data; Organization & Administration; Prevention & Control
- Lewis, Roger J Emergency MedicineDepartment of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California.Subjects: Respiration, Artificial; Anti-Inflammatory Agents; Hydrocortisone; Ascorbic Acid; Conscious Sedation; Coronavirus InfectionsCategories: Therapeutic Use; Drug Therapy; Administration & Dosage; Methods; Statistics & Numerical Data
- Calfee, Carolyn S Critical Care MedicineDivision of Pulmonary, Critical Care, Allergy and Sleep Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA. Top HospitalDisclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $2,400Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Coronavirus Infections; Pneumonia, Viral; Acute Lung Injury; Anti-Inflammatory AgentsCategories: Therapy; Epidemiology; Methods; Administration & Dosage; Drug Therapy; Mortality
- Arabi, Yaseen MCollege of Medicine, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.Subjects: Respiration, Artificial; Critical Care; Respiratory Distress Syndrome; Acute Kidney Injury; Critical Illness; Body Mass IndexCategories: Therapy; Mortality; Methods; Administration & Dosage; Adverse Effects; Blood
- Needham, Dale M Critical Care MedicineDivision of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.Relevant US NIH Grant Funding: $7,164,661 over the last 5 yearsDisclosed payments from biomedical company (GlaxoSmithKline, LLC.) in 2021 for $4,550Subjects: Respiration, Artificial; Acute Lung Injury; Delirium; Intensive Care Units; Respiratory Distress Syndrome; Critical IllnessCategories: Methods; Adverse Effects; Statistics & Numerical Data; Therapy; Mortality; Organization & Administration
- Bellomo, RinaldoDepartment of Intensive Care, Austin Hospital, Melbourne, Australia.Subjects: Respiration, Artificial; Critical Illness; Hypnotics and Sedatives; Oxygen Inhalation Therapy; Oxygen; Conscious SedationCategories: Methods; Administration & Dosage; Therapy; Mortality; Statistics & Numerical Data; Blood
- Girard, Timothy D Emergency MedicineClinical Research, Investigation, and Systems Modeling of Acute Illness CRISMA Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.Relevant US NIH Grant Funding: $1,662,215 over the last 5 yearsSubjects: Respiration, Artificial; Critical Illness; Critical Care; Delirium; Hypnotics and Sedatives; Conscious SedationCategories: Methods; Therapy; Administration & Dosage; Standards; Adverse Effects; Epidemiology
- Gajic, Ognjen Pulmonary DiseaseMayo Clinic, Rochester, USA. Top HospitalRelevant US NIH Grant Funding: $7,023,663 over the last 5 yearsMedical school: Other (MD, 1987)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100Subjects: Respiration, Artificial; Respiratory Insufficiency; Respiratory Distress Syndrome; Electronic Health Records; Intensive Care Units; Oxygen Inhalation TherapyCategories: Methods; Therapy; Mortality; Statistics & Numerical Data; Adverse Effects; Etiology
- Gong, Michelle Ng Critical Care MedicineDivision of Critical Care Medicine, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY. Top HospitalRelevant US NIH Grant Funding: $2,350,982 over the last 5 yearsMedical school: Yale University School of Medicine (MD, 1994)Disclosed payments from biomedical company (Life Technologies Corporation) in 2021 for $1,400Subjects: Respiration, Artificial; Respiratory Distress Syndrome; Critical Illness; Hospital Mortality; Intensive Care Units; COVID-19Categories: Therapy; Methods; Statistics & Numerical Data; Mortality; Therapeutic Use; Standards
- Walkey, Allan J Pulmonary DiseaseBoston University School of Medicine Boston, Massachusetts.Relevant US NIH Grant Funding: $1,772,494 over the last 5 yearsMedical school: University of Massachusetts Medical School (MD, 2002)Medicare AcceptedSubjects: Respiration, Artificial; Respiratory Insufficiency; Life Support Care; Respiratory Distress Syndrome; Critical Illness; Intensive Care UnitsCategories: Statistics & Numerical Data; Epidemiology; Methods; Therapy; Mortality; Antagonists & Inhibitors
- Beitler, Jeremy R Critical Care MedicineCenter for Acute Respiratory Failure, Division of Pulmonary, Allergy, and Critical Care Medicine, NewYork-Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, New York, New York.Physician Clinical TrialRelevant US NIH Grant Funding: $1,114,212 over the last 5 yearsSubjects: Respiration, Artificial; Respiratory Distress Syndrome; Ventilator-Induced Lung Injury; Tidal Volume; Betacoronavirus; Coronavirus InfectionsCategories: Methods; Therapy; Metabolism; Prevention & Control; Adverse Effects; Etiology
- Murthy, SrinivasDepartment of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.Subjects: Respiration, Artificial; COVID-19; Coronavirus Infections; Pneumonia, Viral; Respiratory Distress Syndrome; Anti-Inflammatory AgentsCategories: Statistics & Numerical Data; Therapy; Administration & Dosage; Drug Therapy; Methods; Adverse Effects
- Bernard, Gordon R Pulmonary DiseaseDivision of Pulmonary Critical Care, Vanderbilt University Medical Center, Nashville, Tennessee. Top HospitalPhysician Clinical TrialDisclosed payments in 2021 from 15 biomedical companies, totalling $106,140, including $99,000 from Cumberland Pharmaceuticals, Inc.Subjects: Respiration, Artificial; Conscious Sedation; Intensive Care Units; Sepsis; Activities of Daily Living; Airway ExtubationCategories: Therapeutic Use; Epidemiology; Methods; History; Therapy; Complications
- Rice, Todd W Critical Care MedicineDivision of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Top HospitalPhysician Clinical TrialMedical school: Indiana University School of Medicine (MD, 1997)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 73.2/100Disclosed payments in 2021 from 17 biomedical companies, totalling $32,427.24, including $29,750 from Cumberland Pharmaceuticals, Inc.Subjects: Respiration, Artificial; Critical Illness; Enteral Nutrition; Hypoxia; Intubation, Intratracheal; OxygenCategories: Methods; Therapy; Therapeutic Use; Prevention & Control; Blood; Standards
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.